Vaccination for neonates is a critical component of public health efforts to protect infants from serious infectious diseases. The recommended vaccines for neonates typically include hepatitis B vaccine, administered shortly after birth to prevent perinatal transmission of the virus. Vaccination schedules may vary by country, but common immunizations for neonates often target diseases such as tuberculosis, diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib). These vaccines aim to establish early immunity in vulnerable newborns, offering protection against potentially life-threatening infections. The immune system of neonates is still developing, making timely vaccination essential for safeguarding their health. Vaccination efforts also contribute to herd immunity, protecting those who cannot receive vaccines due to medical reasons. Pediatricians and healthcare providers play a crucial role in educating parents about the importance of following the recommended vaccine schedule for neonates. Ongoing research continues to refine and expand vaccine options for neonatal immunization, ensuring comprehensive protection against preventable diseases during the vulnerable early stages of life.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States